Loading...
Safinamide: an add-on treatment for managing Parkinson’s disease
Heterogeneous expression of neurotransmitter deficits results from onset and progression of Parkinson’s disease. Intervals, characterized by reappearance of motor and associated certain nonmotor symptoms, determine the end of good tolerability and efficacy of oral levodopa therapy. These “OFF” state...
Na minha lista:
| Udgivet i: | Clin Pharmacol |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5896660/ https://ncbi.nlm.nih.gov/pubmed/29670409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S137740 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|